The FDA has approved zolbetuximab-clzb (VYLOY) as a first-line targeted therapy, in combination with chemotherapy, for the ...
Last week’s significant news included Denmark-based CNS drugmaker Lundbeck reaching agreement to acquire US firm Longboard ...
Recent health news includes FDA's approval of Astellas' gastric cancer therapy, the resignation of CVS Health CEO Karen Lynch ...